BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32169946)

  • 1. Comparison and validation of different models and variable selection methods for predicting survival after canine parvovirus infection.
    Franzo G; Corso B; Tucciarone CM; Drigo M; Caldin M; Cecchinato M
    Vet Rec; 2020 Oct; 187(9):e76. PubMed ID: 32169946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings.
    Faz M; Martínez JS; Quijano-Hernández I; Fajardo R
    J Vet Med Sci; 2017 Jan; 79(1):213-217. PubMed ID: 27818461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs.
    Markovich JE; Stucker KM; Carr AH; Harbison CE; Scarlett JM; Parrish CR
    J Am Vet Med Assoc; 2012 Jul; 241(1):66-72. PubMed ID: 22720989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of canine parvovirus infection in dogs.
    Kilian E; Suchodolski JS; Hartmann K; Mueller RS; Wess G; Unterer S
    PLoS One; 2018; 13(3):e0192198. PubMed ID: 29547647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of increased canine pancreas-specific lipase concentrations in young dogs with parvovirus enteritis.
    Kalli IV; Adamama-Moraitou KK; Patsika MN; Pardali D; Steiner JM; Suchodolski JS; Menexes G; Brellou GD; Rallis TS
    Vet Clin Pathol; 2017 Mar; 46(1):111-119. PubMed ID: 28125171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial.
    Martin V; Najbar W; Gueguen S; Grousson D; Eun HM; Lebreux B; Aubert A
    Vet Microbiol; 2002 Oct; 89(2-3):115-27. PubMed ID: 12243889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine parvoviruses in New Zealand form a monophyletic group distinct from the viruses circulating in other parts of the world.
    Ohneiser SA; Hills SF; Cave NJ; Passmore D; Dunowska M
    Vet Microbiol; 2015 Aug; 178(3-4):190-200. PubMed ID: 26031569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine parvovirus: a predicting canine model for sepsis.
    Alves F; Prata S; Nunes T; Gomes J; Aguiar S; Aires da Silva F; Tavares L; Almeida V; Gil S
    BMC Vet Res; 2020 Jun; 16(1):199. PubMed ID: 32539830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
    Iris Kalli ; Leontides LS; Mylonakis ME; Adamama-Moraitou K; Rallis T; Koutinas AF
    Res Vet Sci; 2010 Oct; 89(2):174-8. PubMed ID: 20303134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine parvovirus.
    Goddard A; Leisewitz AL
    Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1041-53. PubMed ID: 20933134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the occurrence of canine parvovirus in dogs.
    Miranda C; Carvalheira J; Parrish CR; Thompson G
    Vet Microbiol; 2015 Oct; 180(1-2):59-64. PubMed ID: 26294318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the Canine Parvovirus 2c Subtype in Australian Dogs.
    Woolford L; Crocker P; Bobrowski H; Baker T; Hemmatzadeh F
    Viral Immunol; 2017 Jun; 30(5):371-376. PubMed ID: 28414634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis.
    Kocaturk M; Martinez S; Eralp O; Tvarijonaviciute A; Ceron J; Yilmaz Z
    J Small Anim Pract; 2010 Sep; 51(9):478-83. PubMed ID: 20630018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
    Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
    J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in canine parvovirus enteritis.
    Schoeman JP; Goddard A; Leisewitz AL
    N Z Vet J; 2013 Jul; 61(4):217-22. PubMed ID: 23477413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of canine parvovirus type 2c in the dogs with haemorrhagic enteritis in India.
    Nandi S; Chidri S; Kumar M; Chauhan RS
    Res Vet Sci; 2010 Feb; 88(1):169-71. PubMed ID: 19552931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, hematological, and biochemical findings in puppies with coronavirus and parvovirus enteritis.
    Castro TX; Cubel Garcia Rde C; Gonçalves LP; Costa EM; Marcello GC; Labarthe NV; Mendes-de-Almeida F
    Can Vet J; 2013 Sep; 54(9):885-8. PubMed ID: 24155496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of certain biomarkers for predicting survival in response to treatment in dogs naturally infected with canine parvovirus.
    Eregowda CG; De UK; Singh M; Prasad H; Akhilesh ; Sarma K; Roychoudhury P; Rajesh JB; Patra MK; Behera SK
    Microb Pathog; 2020 Dec; 149():104485. PubMed ID: 32926999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central role of chloride in the metabolic acid-base changes in canine parvoviral enteritis.
    Burchell RK; Schoeman JP; Leisewitz AL
    Vet J; 2014 Apr; 200(1):152-6. PubMed ID: 24613416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.
    Yip HYE; Peaston A; Woolford L; Khuu SJ; Wallace G; Kumar RS; Patel K; Ahani Azari A; Akbarzadeh M; Sharifian M; Amanollahi R; Jafari Jozani R; Khabiri A; Hemmatzadeh F
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.